JooGood Inc.

Adjustable chest cuirass coupled with negative pressure ventilator for pulmonary rehabilitation in patients with respiratory disease and long-term healthy care

JW Diagnostics Inc.

JW Diagnostics Inc. provides comprehensive and high-quality tests and molecular analysis services for precision medicine in the fields of preventive health management, maternal and child care, and medical decision-making for cancer therapies by cooperating with Taipei Medical University.
1. preventive health management: IMR AD Assay, genetic analysis for medication-use safety, Alcohol metabolic genes assay, Fecal microbiota analysis, neurodegenerative disease genes analysis.
2. maternal and child care: NIPS, Fragile X syndrome test, SMA gene test, genetic disease carrier analysis, rare disease genetic analysis, inherited hearing loss genes analysis, genetic analysis for NICU.
3. medical decision-making for cancer therapies: personized anti-cancer medicine analysis (including chemotherapy and target therapy), companion test, early-stage screening and follow-up analysis for tumors, liquid biopsy tests (ctDNA and CTC), tests for immunotherapy (MSI and PD-L1), clinical exome analysis, WES, and WGS.

Kaohsiung Chang Gung Memorial Hospital

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders among children and adolescents. MicroRNAs (miRNAs) are involved in the process of RNA silencing and the post-transcriptional regulation of gene expression, and miRNAs may play an important role in neurodevelopment. The next-generation sequencing (NGS) technique was used to identify 13 miRNAs as potential ADHD biomarkers. The ΔCt values of these miRNAs were integrated to create a biomarker model using the support vector machine (SVM) algorithm, which demonstrated good validity in differentiating ADHD patients from control subjects (sensitivity: 96%, specificity: 94.2%). Our basic studies also provide physiological evidence to support that our miRNA biomarkers potentially affect neurodevelopment and brain structure.
As measured in peripheral blood, miRNA-based biomarkers can aid in the differentiation of ADHD in clinical settings. We have developed a pioneer model of molecular diagnosis for detecting ADHD through the use of combinations of multiple miRNA expressions for assisting clinical diagnosis. This invention was awarded in the 2020 National Innovation Award, and has obtained the certification of patents in Taiwan (I690595) and in Europe (No.3369829). Therefore, our invention is accurate, fast, and convenient, and has a wide range of needs and a high degree of clinical practicality.

Kaohsiung Chang Gung Memorial Hospital

Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays-only on drop of blood

Kaohsiung Chang Gung Memorial Hospital

Using miRNAs to develop the molecular diagnosis method for Kawasaki disease

Kaohsiung Chang Gung Memorial Hospital

the Device of Artificial Stoma

Kaohsiung Chang Gung Memorial Hospital/ National Chiao Tung University

Optical Detection Device for Fever and Kawasaki Disease

Kaohsiung Medical University

Kaohsiung Medical University

Development of smart lower limb rehabilitation robot controlled by Brain-Computer-Interface and clinical experiment

Kaohsiung Medical University

Vaginal Surgical Speculum